32
Participants
Start Date
August 3, 2020
Primary Completion Date
November 3, 2020
Study Completion Date
November 3, 2020
Administration of BioChaperone insulin lispro reconstituted with Humalog® (IMP1)
Administration of IMP1 during a 12-hour euglycaemic clamp.
Administration of Ready-to-use BioChaperone insulin lispro (IMP2)
Administration of IMP2 during a 12-hour euglycaemic clamp.
Administration of US-approved Humalog® (IMP3)
Administration of IMP3 during a 12-hour euglycaemic clamp.
Administration of EU-approved Humalog® (IMP4)
Administration of IMP4 during a 12-hour euglycaemic clamp.
Profil GmbH, Mainz
Lead Sponsor
Adocia
INDUSTRY